2309 Stock Overview
CMIC HOLDINGS Co., Ltd. provides pharmaceutical development services in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
CMIC HOLDINGS Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,644.00 |
| 52 Week High | JP¥2,657.00 |
| 52 Week Low | JP¥1,616.00 |
| Beta | 0.56 |
| 1 Month Change | 0.11% |
| 3 Month Change | 0.076% |
| 1 Year Change | 26.57% |
| 3 Year Change | 69.81% |
| 5 Year Change | 70.69% |
| Change since IPO | 76.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2309 | JP Life Sciences | JP Market | |
|---|---|---|---|
| 7D | 0.2% | -2.9% | -1.5% |
| 1Y | 26.6% | -13.7% | 13.7% |
Return vs Industry: 2309 exceeded the JP Life Sciences industry which returned -28.6% over the past year.
Return vs Market: 2309 underperformed the JP Market which returned 35.7% over the past year.
Price Volatility
| 2309 volatility | |
|---|---|
| 2309 Average Weekly Movement | 0.3% |
| Life Sciences Industry Average Movement | 5.5% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 2309 has not had significant price volatility in the past 3 months.
Volatility Over Time: 2309's weekly volatility has decreased from 6% to 0% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 4,684 | Kazuo Nakamura | www.cmicgroup.com |
CMIC HOLDINGS Co., Ltd. provides pharmaceutical development services in Japan. The company offers clinical trial services, including audit and quality assurance, clinical operations and trials, data management, clinical caretaker, patient recruitment, pharmacovigilance, project management, and statistical analysis; and clinical site network, CMC, drug development, health economics and outcome research, market entry/out-licensing, medical devices and in vitro diagnostic consulting, medical writing, national health insurance/drug pricing, and product life cycle management consulting services. It also provides development and manufacturing services, including commercial supply, contract development and manufacturing, investigational product manufacturing, packaging and labeling, release and stability tests, and technology transfer, as well as formulation development services; and laboratory services, such as bioanalysis and GLP analysis, biomarkers, CMC and GMP analysis, large molecule, oligonucleotides, small molecule, and toxicity, as well as efficacy and safety pharmacology, in vitro and in vivo, and non-clinical studies.
CMIC HOLDINGS Co., Ltd. Fundamentals Summary
| 2309 fundamental statistics | |
|---|---|
| Market cap | JP¥44.69b |
| Earnings (TTM) | JP¥5.33b |
| Revenue (TTM) | JP¥93.11b |
8.4x
P/E Ratio0.5x
P/S RatioIs 2309 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2309 income statement (TTM) | |
|---|---|
| Revenue | JP¥93.11b |
| Cost of Revenue | JP¥72.30b |
| Gross Profit | JP¥20.81b |
| Other Expenses | JP¥15.48b |
| Earnings | JP¥5.33b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 315.19 |
| Gross Margin | 22.35% |
| Net Profit Margin | 5.72% |
| Debt/Equity Ratio | 7.1% |
How did 2309 perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield13%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/04/01 07:49 |
| End of Day Share Price | 2024/04/01 00:00 |
| Earnings | 2023/12/31 |
| Annual Earnings | 2023/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
CMIC HOLDINGS Co., Ltd. is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ritsuo Watanabe | BofA Global Research |
| Akitada Iwasa | Daiwa Securities Co. Ltd. |
| Masao Yoshida | Ichiyoshi Research Institute Inc. |